Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation

Authors:
Wellbrock C and Marais R
In:
Source: J Cell Biol
Publication Date: (2005)
Issue: 170(5): 703-708
Research Area:
Cancer Research/Cell Biology
Dermatology/Tissue Engineering
Cells used in publication:
Melanocyte, (NHEM-neo), human neonatal
Species: human
Tissue Origin: dermal
Melanocyte, (NHEM-Ad), human adult
Species: human
Tissue Origin: dermal
Platform:
Nucleofector® I/II/2b
Abstract
The protein kinase B-RAF is a human oncogene that is mutated in approximately 70% of human melanomas and transforms mouse melanocytes. Microphthalmia-associated transcription factor (MITF) is an important melanocyte differentiation and survival factor, but its role in melanoma is unclear. In this study, we show that MITF expression is suppressed by oncogenic B-RAF in immortalized mouse and primary human melanocytes. However, low levels of MITF persist in human melanoma cells harboring oncogenic B-RAF, suggesting that additional mechanisms regulate its expression. MITF reexpression in B-RAF-transformed melanocytes inhibits their proliferation. Furthermore, differentiation-inducing factors that elevate MITF expression in melanoma cells inhibit their proliferation, but when MITF up-regulation is prevented by RNA interference, proliferation is not inhibited. These data suggest that MITF is an antiproliferation factor that is down-regulated by B-RAF signaling and that this is a crucial event for the progression of melanomas that harbor oncogenic B-RAF.